Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLunch on Mounjaro tends to arrive with a surprise: you're simply not as hungry as you expected. Clinical trials of tirzepatide found that appetite suppression is consistent across the day, not just at breakfast or dinner, so the midday meal is often where people first notice how dramatically food cravings have shifted. That's useful, but it also creates a practical question: if you can eat far less, what should those smaller Mounjaro lunches actually contain? The answer, backed by NHS guidance on weight-management medicines, matters for how well the treatment works and how you feel on it. Mounjaro is a prescription-only medicine; a prescriber assesses whether it's right for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
SURMOUNT-1, published in the New England Journal of Medicine, randomised 2,539 adults with obesity and tracked them for 72 weeks. At the highest 15mg dose, participants lost an average of around 20–21% of their body weight. A large part of that reduction came from eating less, not just moving more. Participants reported feeling full sooner and staying full longer, and that effect was consistent through the day, including at lunch.
Tirzepatide is a dual GIP and GLP-1 receptor agonist: it acts on two gut-hormone pathways simultaneously, slowing how quickly the stomach empties and increasing satiety signals to the brain. The practical upshot at lunchtime is that a portion which would previously have left you reaching for a second plate can feel genuinely sufficient. That's not a willpower achievement; it's the medicine doing what it's designed to do.
The risk worth knowing about: when total food intake drops sharply, it becomes easy to eat far less protein than your body needs. NHS guidance on weight-management injections flags muscle preservation as a key reason dietary quality matters alongside reduced quantity. A smaller lunch that's protein-anchored is meaningfully better than a smaller lunch that isn't. Think of it as the evidence pointing toward what goes on the plate, not just how much.
You'll find fuller practical ideas on our Mounjaro lunch ideas page, but the principles are worth setting out here. Three things should anchor a midday meal on tirzepatide: adequate protein, enough fibre to support satiety and digestive health, and a moderate amount of fat rather than a high-fat load.
Protein targets matter. Most adults need somewhere between 1.2g and 1.6g of protein per kilogram of body weight per day when losing weight, to protect lean mass. At lunch, that might mean 25–35g of protein from sources like chicken breast, eggs, tinned fish, Greek yoghurt, legumes or tofu. The exact number is something to discuss with your prescriber or a registered dietitian, because individual needs vary.
Fibre is useful for two reasons on Mounjaro: it keeps the digestive system moving (constipation is a reported side effect of tirzepatide), and it adds bulk to a smaller meal without adding many calories. Vegetables, pulses, and wholegrains earn their place on the plate.
High-fat lunches are worth moderating. Because gastric emptying is already slowed on tirzepatide, a very fatty meal can sit heavily and worsen nausea, particularly in the first few weeks of a new dose. That doesn't mean fat is banned; it means a large portion of chips with a creamy sauce is a worse choice on Mounjaro than it might have been before. The NHS tirzepatide patient information page notes nausea and stomach discomfort among the most common side effects, and food choices at mealtimes can genuinely reduce their frequency.
Here's the thing most people don't expect to worry about on a weight-loss medicine: losing muscle. When calorie intake drops significantly, the body can draw on muscle protein as well as fat stores. Tirzepatide's appetite suppression is powerful, and some people, without planning their meals, end up eating so little protein that muscle mass falls faster than it should.
Lunch is often the meal where this goes wrong. Breakfast might be eggs or yoghurt, dinner might include fish or chicken, but lunch becomes a small salad, a plain rice cake, or skipped altogether. Over weeks, that adds up. A structured approach to lunch on Mounjaro is one of the simplest ways to close the protein gap for the day without forcing yourself to eat more than feels comfortable.
Strength or resistance activity alongside treatment is recommended in the NHS wraparound guidance precisely because it signals the body to retain muscle even in a calorie deficit. Lunch is also a natural time to think about a short walk, which helps with both blood sugar regulation and digestion.
If you're concerned about side effects beyond appetite changes, our page on aches on Mounjaro covers what's known about physical symptoms and when to seek advice. Unexplained muscle weakness or significant fatigue is worth raising with your prescriber rather than waiting it out.
Mounjaro is injected once a week, and appetite suppression does not tend to peak dramatically around the injection day for most people, though some notice increased nausea in the 24–48 hours after dosing. If you're curious about how the treatment is being used locally, our Mounjaro Manchester page gives a sense of how people across the region are approaching it, including the practical scheduling questions that come up most often. Regular meal timing helps. Skipping lunch because appetite is low can lead to low energy, headaches, and worse nausea later in the day. Small and consistent beats large and erratic. Even if the meal is modest, sitting down to eat at a predictable time gives the body a rhythm that tends to ease the GI side effects that are common in the early weeks.
Hydration through the working day deserves its own mention. Nausea and fatigue are both amplified by mild dehydration, and the sensation of thirst can be blunted on tirzepatide just as hunger is. A glass of water with lunch and regular sips through the afternoon costs nothing and helps more than most people expect.
If you're thinking about starting treatment and want to understand the broader picture, the weight-loss treatment overview sets out how Mounjaro sits alongside lifestyle changes. Decisions about your specific dose, meal plan and timing are made between you and your prescriber, not by a food list on a website, but knowing what the evidence says about lunches gives you a better starting point for that conversation, and if you're looking for something a little different, our Mounjaro bauble makes a thoughtful gift for someone on their weight-loss journey. When you're ready to take that step, start your free consultation with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.